// App-Quantinova.ai

TCT-509 : Eighteen-month results of high-risk patients treated with ultrathin-strut biodegradable-polymer Orsiro DES. The Bioflow-III Satellite Italy Subgroups analysis.

Researchers

Presenter

  • Stefano Galli

Principal Investigators

  • Francesco Versaci

  • Carlo Briguori

  • Fabrizio Tomai

  • Arnaldo Poli

  • Carlo Vigna

  • Luigi My

  • Filippo Masi

  • Maurizio Turturo

  • Antonio Bartorelli

Medical Centers

  • European Hospital, Dept. Cardiovascular Sciences, Rome, Italy

  • Cardiology Unit, Casa di Cura Villa Verde, Taranto, Italy., Taranto, Taranto, Italy

  • Di Venere Hospital, Carbonara di Bari, Barletta-Andria-Trani, Italy

  • Centro Cardiologico Monzino, Milan, Italy

  • Clinica Mediterranea, Naples, Naples, Italy

  • Ospedale Santa Maria Goretti, Latina, Latina, Italy

  • CSS IRCCS, San Giovanni Rotondo, Foggia, Italy

  • Ospedale Civile, Legnano, Italy, Legnano, Milan, Italy

  • Cardiologia Universitaria Policlinico Bari, Valenzano, Bari, Italy

  • Department of Clinical Sciences and Community Health, Centro Cardiologico Monzino, IRCCS, Milan, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved